Amniotic stem cell injections are becoming more popular in orthopedics and sports medicine because they don't have the same ethical ramifications that other treatments have. They are highly effective and less invasive than other types of therapy.
Stem cells are the body's generative powerhouses. They produce all other specialized cells in the body. No other type of cell in the body can turn into a liver cell, a bone cell, or a blood cell. Under optimal lab conditions, stem cells divide, creating daughter cells that can either become new stem cells or specialized cells.
Scientists and medical researchers have a keen interest in amniotic stem cell treatment because it can give insight into other diseases, test new medicines and treatments for efficacy, and treat patients with regenerative medicine.
Amniotic stem cell therapy is less controversial than other types of stem cell therapy because, instead of harvesting stem cells from embryos, doctors harvest these useful cells from the amniotic fluid surrounding the embryo during gestation.
As people age, they look for more ways to promote regeneration in their aging bodies. Amniotic stem cell treatment can enhance this process by increasing the repair response of diseases or dysfunctional cells.
Stem cells are a step up from organ transplantation in regenerative medicine. Instead of finding an organ to transplant, which is difficult because of the limited number of organs, doctors can implant amniotic cells into a patient. These amniotic stem cells help boost the other cells’ repair response, helping repair the damaged organ more quickly.
A huge benefit of these cell types is their versatility; bone marrow stem cells can be changed into heart cells to help repair damage to a failing heart. Scientists have discovered that mesenchymal stem cells can make several different cells, like bone marrow cells and skeletal cells.¹
Doctors implant stem cells in patients to help increase the regenerative powers of the cells. Especially with amniotic stem cells, doctors have identified over 225 growth factors in amniotic biological material. For those with fasciitis or other joint difficulties like tennis elbow or rotator cuff issues, amniotic stem cell therapy may be a viable solution.
In orthopedic and sports medicine, stem cell therapy has been very beneficial for treating ligament, tendon, and joint problems, which active adults often face as they age. The stem cells derived from the amniotic fluid are of great use in the medical world because they are rarely rejected by the body. ²
Stem cell injections can treat osteoarthritis symptoms to bone fractures. Since the stem cells are taken from the amniotic membrane, there are not the same ethical dilemmas that arise with embryonic stem cells. This treatment is also an ideal option for patients on medications such as blood thinners who want to avoid any adverse reactions to treatment.
Amniotic stem cell therapy can be used in conjunction with other regenerative therapies or can be used by the patient without additional therapies, depending on the severity of the condition. Usually, in orthopedics and sports medicine, wear and tear on joints and ligaments may mean invasive surgeries or medication.³ Stem cell treatment is less invasive than other treatments and, depending on what type of cells, more effective.
Stem cells implanted in a damaged area like a rotator cuff or Achilles' tendon tear will produce healthy cells for up to a year after implantation. However, it takes the patient only two to three weeks to start benefiting from the therapy.
With the expertise of an orthopedic surgeon vetted by BioStem Technologies, the wonders of amniotic stem cell therapy, and consistent physical therapy post-surgery, patients feel much less pain in a shorter amount of time.
Although stem cell therapy has been used for years in other medical specialties, it is relatively new to the sports medicine and orthopedic world, and it is very promising.
(1) Ullah, I., Subbarao, R., & Rho, G. (2015, April 28). Human mesenchymal stem cells - current trends and future prospective.
(2) Borlongan, C. (2017). Amniotic fluid as a source of engraftable stem cells.
(3) Akpancar, S., Tatar, O., Turgut, H., Akyildiz, F., & Ekinci, S. (2016, August 16). The Current Perspectives of Stem Cell Therapy in Orthopedic Surgery.